Back to search

Article

Clinical performance of the Roche Elecsys SARS-CoV-2 Antigen fully automated electrochemiluminescence immunoassay

2021-10-06

Abstract excerpt

<h4>Objective: </h4> We assessed the clinical performance of novel Roche Elecsys SARS-CoV-2 Antigen fully automated electrochemiluminescence immunoassay (ECLIA). <h4>Design: </h4> and Methods We tested 160 subjects, 110 (68.8%) with positive molecular test for SARS-CoV-2 infection in nasopharyngeal samples with Altona Diagnostics RealStar SARS-CoV-2 RT-PCR Kit and Roche Elecsys SARS-CoV-2 Antigen. The local imprec...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
38bcdeae-2518-5080-a1ff-ff10c4d096ec
DOI
10.21203/rs.3.rs-957329/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Clinical performance of the Roche Elecsys SARS-CoV-2 Antigen fully automated electrochemiluminescence immunoassayDOI 10.21203/rs.3.rs-957329/v1
Select a neighboring publication to make it the new centre.